| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 09/10/1996 | US5554724 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
| 09/10/1996 | US5554596 Polymer with lignin units and lignoid units |
| 09/10/1996 | US5554527 Agent for the storage and suspension of cells, especially erythrocytes |
| 09/10/1996 | US5554506 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 09/10/1996 | US5554389 Urinary bladder submucosa derived tissue graft |
| 09/10/1996 | US5554361 Iodine, cod liver oil |
| 09/10/1996 | US5554148 Renewable neural implant device and method |
| 09/10/1996 | CA2171242A1 Msrv-1 virus and pathogenic and/or infective msrv-2 related to rhumatoid arthritis |
| 09/06/1996 | WO1996026742A1 Gene transfer-mediated angiogenesis therapy |
| 09/06/1996 | WO1996026732A1 Compositions of lactic acid bacteria and saccharomyces lysates and the therapeutical use thereof |
| 09/06/1996 | WO1996021035A3 Retroviral delivery of full length factor VIII |
| 09/06/1996 | WO1996019965A3 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 09/06/1996 | CA2188575A1 Gene transfer-mediated angiogenesis therapy |
| 09/04/1996 | EP0730032A2 Process for preparing sphingomyelin and ceramide from erythrocyte as a starting material and a curing agent or cosmetic formulated with ceramide |
| 09/04/1996 | EP0729516A1 Recombinant adenoviruses for gene therapy in cancers |
| 09/04/1996 | EP0729515A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting |
| 09/04/1996 | EP0729511A1 Compositions and methods for utilizing conditionally lethal genes |
| 09/04/1996 | EP0729507A1 Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor |
| 09/04/1996 | EP0729506A1 Myocardial grafts and cellular compositions useful for same |
| 09/04/1996 | EP0729325A1 Osteogenic product and process |
| 09/04/1996 | EP0729297A1 Hepatoblasts and method of isolating same |
| 09/04/1996 | EP0560932B1 Methods and compositions for the suppression of neu mediated transformation |
| 09/04/1996 | CN1130086A Quick-action defatting liquid and its preparing method |
| 09/04/1996 | CN1130085A Hyperthyroidism plaster and its preparing method |
| 09/04/1996 | CN1130068A Oral liquor of snake essence |
| 09/04/1996 | CN1130067A Chum salmon white essence oral liquor and its production technique |
| 09/04/1996 | CN1032693C Growth hormone for hepatocyte |
| 09/03/1996 | US5552161 Low viscosity, highly concentrated surfactant suspension |
| 09/03/1996 | CA2059632C Reveromycin a, method for preparing same, and antitumor agent and antifungal agent comprising the same |
| 09/03/1996 | CA1338570C Endowing cells with antibody specificity |
| 08/29/1996 | WO1996026288A1 A method for the isolation and purification of lipid cell-wall components |
| 08/29/1996 | WO1996026286A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 08/29/1996 | WO1996026285A2 Methods and compositions for administering gene therapy vectors |
| 08/29/1996 | WO1996026281A1 Chimeric adenoviral fiber protein and methods of using same |
| 08/29/1996 | WO1996026271A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof |
| 08/29/1996 | WO1996026267A1 Viral preparations, vectors, immunogens, and vaccines |
| 08/29/1996 | WO1996026265A1 Redirection of cellular immunity by protein-tyrosine kinase chimeras |
| 08/29/1996 | WO1996025953A1 Redirection of cellular immunity by receptor chimeras |
| 08/29/1996 | WO1996025941A1 Modulators of regulatory proteins |
| 08/29/1996 | WO1996025848A1 Method for diluting and preserving rabbit semen |
| 08/29/1996 | WO1996019580A3 Telomerase protein component |
| 08/29/1996 | WO1996018737A3 Vectors and viruses for use in gene therapy |
| 08/29/1996 | WO1996014412A3 cDNA ENCODING A BMP TYPE II RECEPTOR |
| 08/29/1996 | DE19506362A1 Prodn. of cytokine mixt. for use in cancer therapy |
| 08/29/1996 | CA2213484A1 Modulators of regulatory proteins |
| 08/29/1996 | CA2213451A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof |
| 08/29/1996 | CA2213439A1 Methods and compositions for administering gene therapy vectors |
| 08/29/1996 | CA2213428A1 A method for the isolation and purification of lipid cell-wall components |
| 08/29/1996 | CA2211743A1 Viral preparations, vectors, immunogens, and vaccines |
| 08/28/1996 | EP0728209A1 Endothelin-converting enzyme |
| 08/28/1996 | EP0728202A1 Episomal expression vector for human gene therapy |
| 08/28/1996 | EP0728200A1 Haemophilus transferrin receptor genes |
| 08/28/1996 | EP0728195A1 Methods for preserving recombinant viruses |
| 08/28/1996 | EP0728194A1 $i(IN SITU) MODIFICATION AND MANIPULATION OF STEM CELLS OF THE CENTRAL NERVOUS SYSTEM |
| 08/28/1996 | EP0728193A1 Method for mammalian cell separation from a mixture of cell populations |
| 08/28/1996 | EP0728142A1 Novel antler-derived bone growth factors |
| 08/28/1996 | EP0728023A1 Soluble factor stimulation of attachment and hemidesmosome assembly in epithelial cells |
| 08/28/1996 | EP0728017A1 Treatment of bacterially-induced inflammatory diseases |
| 08/28/1996 | EP0728013A1 Compositions and method for stimulating antibody release by b lymphocytes |
| 08/28/1996 | EP0728010A1 Method for treating hepatitis b carriers with minimal disease |
| 08/28/1996 | EP0727938A1 Device and method for photoactivation |
| 08/28/1996 | EP0313578B1 Novel osteoinductive compositions |
| 08/28/1996 | CN1129584A Medicine for rheumatism |
| 08/28/1996 | CN1129574A Pellet cosmetic products and preparation thereof |
| 08/28/1996 | CN1129560A Fast effective Tangshanglin for curing scald |
| 08/28/1996 | CN1129559A Suxiaozhi injection liquid for haemorrhoids and preparation thereof |
| 08/27/1996 | US5550178 Process for encapsulating biologics using crosslinkable biocompatible encapsulation system |
| 08/27/1996 | US5550108 Adding an 18 kda c5b-9 inhibitory protein to prevent platelet and endothelial cell activation |
| 08/27/1996 | US5550060 Method and procedure for preparing red blood fractions |
| 08/27/1996 | US5550050 Exposing cells enclosed in biocompatible capsules to restrictive environmental conditions which match those which will be encountered after implantation until desired responses are established |
| 08/27/1996 | US5550019 Methods of identifying compounds which alter apoptosis |
| 08/27/1996 | US5549674 Methods and compositions of a bioartificial kidney suitable for use in vivo or ex vivo |
| 08/22/1996 | WO1996025520A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth |
| 08/22/1996 | WO1996025511A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF |
| 08/22/1996 | WO1996025506A1 Method for preparing a recombinant adenovirus genome |
| 08/22/1996 | WO1996025494A1 Transcription factor - e2f-5 |
| 08/22/1996 | WO1996025487A1 Materials and methods relating to the regulation of polypeptide production in cells |
| 08/22/1996 | WO1996025423A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |
| 08/22/1996 | WO1996025179A1 Composition and method for production of transformed cells |
| 08/22/1996 | WO1996025178A1 ANTI-TRANSFORMING GROWTH FACTOR-β GENE THERAPY |
| 08/22/1996 | WO1996025177A1 Medicinal combination useful for in vivo exogenic transfection and expression |
| 08/22/1996 | DE19505744A1 Compsn. and appts. for electro-physical therapy |
| 08/22/1996 | CA2213315A1 Inhibition and modulation of gonadotropin-releasing hormone receptor activity |
| 08/22/1996 | CA2213132A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth |
| 08/22/1996 | CA2211975A1 Transcription factor - e2f-5 |
| 08/22/1996 | CA2211101A1 Materials and methods relating to the regulation of polypeptide production in cells |
| 08/21/1996 | EP0726948A1 Method of inducing and maintaining neuronal cells |
| 08/21/1996 | EP0726941A1 METHODS FOR $i(EX VIVO) THERAPY USING PEPTIDE-LOADED ANTIGEN PRESENTING CELLS FOR THE ACTIVATION OF CTL |
| 08/21/1996 | EP0726913A1 Cytokines from natural killer or t cells |
| 08/21/1996 | EP0726779A1 Methods of stimulating phagocytosis |
| 08/21/1996 | EP0726773A1 Method for inhibiting angiogenesis using heparinase |
| 08/21/1996 | EP0726772A1 A method for sensitization of cancer cells for killer cell mediated lysis |
| 08/21/1996 | EP0726767A1 Biochemically active agents for chemical catalysis and cell receptor activation |
| 08/21/1996 | EP0726758A1 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis b virus |
| 08/21/1996 | EP0671923A4 Liver reserve cells. |
| 08/21/1996 | EP0593440B1 Use of honey as vaccine |
| 08/21/1996 | CN1129111A Ointment for treatment of silkworker's dermatitis |
| 08/21/1996 | CN1129110A Preparation method for lameness-relieving injection |
| 08/20/1996 | US5547959 For treatment of the autoimmune disease systemic lupus erythematosus |
| 08/20/1996 | US5547932 Transfection |